The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
In the latest session, Capricor Therapeutics Inc (NASDAQ: CAPR) closed at $24.79 up 1.14% from its previous closing price of $24.51. In other words, the price has increased by $1.14 from its previous closing price. On the day, 0.72 million shares were traded. CAPR stock price reached its highest trading level at $25.36 during the session, while it also had its lowest trading level at $24.12.
Ratios:
For a deeper understanding of Capricor Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.59 and its Current Ratio is at 3.59. In the meantime, Its Debt-to-Equity ratio is 0.21 whereas as Long-Term Debt/Eq ratio is at 0.17.
Upgrades & Downgrades
In the most recent recommendation for this company, Alliance Global Partners on June 30, 2025, initiated with a Buy rating and assigned the stock a target price of $20.
On June 26, 2025, B. Riley Securities started tracking the stock assigning a Buy rating and target price of $21.
On May 20, 2025, Roth Capital started tracking the stock assigning a Buy rating and target price of $31.Roth Capital initiated its Buy rating on May 20, 2025, with a $31 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CAPR now has a Market Capitalization of 1348558336 and an Enterprise Value of 1049337792. For the stock, the TTM Price-to-Sale (P/S) ratio is 121.17 while its Price-to-Book (P/B) ratio in mrq is 13.51. Its current Enterprise Value per Revenue stands at 94.276 whereas that against EBITDA is -12.357.
Stock Price History:
The Beta on a monthly basis for CAPR is 0.37, which has changed by 0.81959915 over the last 52 weeks, in comparison to a change of 0.1726681 over the same period for the S&P500. Over the past 52 weeks, CAPR has reached a high of $40.37, while it has fallen to a 52-week low of $4.30. The 50-Day Moving Average of the stock is 39.26%, while the 200-Day Moving Average is calculated to be 126.69%.
Shares Statistics:
For the past three months, CAPR has traded an average of 2.81M shares per day and 1501290 over the past ten days. A total of 54.40M shares are outstanding, with a floating share count of 47.82M. Insiders hold about 12.11% of the company’s shares, while institutions hold 31.87% stake in the company. Shares short for CAPR as of 1767139200 were 5064287 with a Short Ratio of 1.80, compared to 1764288000 on 16419579. Therefore, it implies a Short% of Shares Outstanding of 5064287 and a Short% of Float of 10.3599995.
Earnings Estimates
The market rating of Capricor Therapeutics Inc (CAPR) is currently shaped by the ongoing analysis conducted by 7.0 analysts closely monitoring its performance.The consensus estimate for the next quarter is -$0.5, with high estimates of -$0.44 and low estimates of -$0.54.
Analysts are recommending an EPS of between -$2.02 and -$2.23 for the fiscal current year, implying an average EPS of -$2.16. EPS for the following year is $0.15, with 7.0 analysts recommending between $3.09 and -$2.36.
